Top Markets
Coin of the day
Enzo Biochem, Inc. Enzo Biochem, Inc.

Enzo Biochem, Inc.

ENZ
Κατάταξη σε μετοχές #28164
Enzo Biochem, Inc. is a diversified enterprise that encompasses diagnostics,... Enzo Biochem, Inc. is a diversified enterprise that encompasses diagnostics, clinical laboratory services, and life sciences. The company's core activities involve the entire process of researching, developing, manufacturing, and commercializing diagnostic and scientific investigation products, drawing upon advancements in genetic engineering, biotechnology, and molecular biology. Its operations are organized into three primary segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. The Life Sciences Products division is responsible for creating, producing, and distributing vital tools and reagents tailored for customers in clinical research, pharmaceutical development, and broader bioscience research. Its extensive product catalog features items such as proteins, antibodies, peptides, small molecules, labeling agents, dyes, and various kits. These offerings provide life science researchers with the means for target identification and validation, content analysis, gene expression studies, nucleic acid detection, protein biochemistry and detection, and cellular analysis. This segment also supplies specialized solutions to scientific experts investigating critical health areas, including cancer, cardiovascular ailments, neurological disorders, metabolic conditions (like diabetes and obesity), endocrine imbalances, infectious and autoimmune diseases, hepatotoxicity, and renal injury. The Clinical Laboratory Services segment delivers a comprehensive spectrum of molecular and other clinical laboratory tests and procedures. These are utilized by physicians in routine patient care to help confirm or establish diagnoses, monitor the effectiveness of treatments or medications, and identify previously undiagnosed medical conditions. This division operates a central, full-service clinical laboratory in Farmingdale, New York, complemented by a network of 30 patient service centers across New York and New Jersey. Additionally, it runs dedicated "STAT" or rapid-response laboratories in New York City and Connecticut, alongside a full-service phlebotomy facility and an internal logistics department. The Therapeutics segment is dedicated to pioneering novel treatment approaches within the fields of gastrointestinal, infectious, ophthalmic, and metabolic diseases. Enzo Biochem distributes its array of products and services through its dedicated internal sales team and an extensive network of distributors, reaching both domestic and international markets. The company was established in 1976 and has its corporate headquarters situated in New York, New York.
Τιμή μετοχής
$0.5495
Τελευταίος συγχρονισμός: 2025-05-15
Κεφαλαιοποίηση
$28.14M
Αλλαγή (1 ημέρα)
4.70%
Αλλαγή (1 έτος)
0.00%
Χώρα
US
Εμπόριο Enzo Biochem, Inc. (ENZ)

Κατηγορία

Λειτουργικό Περιθώριο για Enzo Biochem, Inc. (ENZ)
Λειτουργικό Περιθώριο στις August 2026 TTM: -30.77%
Σύμφωνα με τις τελευταίες οικονομικές αναφορές και την τιμή μετοχής της Enzo Biochem, Inc., το τρέχον Λειτουργικό Περιθώριο (TTM) είναι -30.77%. Στο τέλος του 2023, το Λειτουργικό Περιθώριο ήταν -79.64%.
Ιστορικό Λειτουργικού Περιθωρίου για την Enzo Biochem, Inc. από 2000 έως 2026
Λειτουργικό Περιθώριο στο τέλος κάθε έτους
Έτος Λειτουργικό Περιθώριο Αλλαγή
2026 (TTM) -30.77% 0.00%
2024 -30.77% -61.36%
2023 -79.64% 450.00%
2022 -14.48% -272.59%
2021 8.39% -126.99%
2020 -31.09% -132.30%
2019 96.26% -928.40%
2018 -11.62% 309.15%
2017 -2.84% -106.21%
2016 45.73% -3,787.90%
2015 -1.24% -88.31%
2014 -10.61% -47.60%
2013 -20.25% -48.43%
2012 -39.27% 209.94%
2011 -12.67% -44.23%
2010 -22.72% -15.41%
2009 -26.86% 41.29%
2008 -19.01% -52.03%
2007 -39.63% -21.68%
2006 -50.60% 113.14%
2005 -23.74% -19.17%
2004 -29.37% -454.71%
2003 8.28% -50.24%
2002 16.64% 5.32%
2001 15.80% 55.51%
2000 10.16% 0.00%
Λειτουργικό Περιθώριο για παρόμοιες εταιρείες ή ανταγωνιστές
Εταιρεία Λειτουργικό Περιθώριο Διαφορά Λειτουργικού Περιθωρίου Χώρα
17.69% -100.57%
US
20.42% -100.66%
US
0.00% -
CN
-10.70% -99.65%
US
32.03% -101.04%
US
Τι είναι το Λειτουργικό Περιθώριο μιας εταιρείας;
Το Λειτουργικό Περιθώριο είναι ένας βασικός δείκτης για την αξιολόγηση της κερδοφορίας μιας εταιρείας. Όσο υψηλότερο είναι το Operating Margin, τόσο το καλύτερο, καθώς δείχνει ότι η εταιρεία πωλεί τα προϊόντα ή τις υπηρεσίες της με σημαντικό περιθώριο κέρδους. Υπολογίζεται διαιρώντας τα κέρδη της εταιρείας με τα έσοδά της.